John L Buse from Saint Charles, MO

Professional Records

Medicine Doctors

John B. Buse

View page

Specialties:

Endocrinology, Diabetes & Metabolism, Diabetes

Work:

University Of North Carolina Hospitals Diabetes & Endocrinology At Meadowmont
300 Meadowmont Vlg Cir STE 202, Chapel Hill, NC 27517
(984) 974-2950 (phone), (984) 974-2924 (fax)

Education:

Medical School
Duke University School of Medicine
Graduated: 1986

Conditions:

Diabetes Mellitus (DM)
Disorders of Lipoid Metabolism
Hypertension (HTN)
Hyperthyroidism
Hypothyroidism

Languages:

Chinese
English
Spanish

Description:

Dr. Buse graduated from the Duke University School of Medicine in 1986. He works in Chapel Hill, NC and specializes in Endocrinology, Diabetes & Metabolism and Diabetes. Dr. Buse is affiliated with North Carolina Memorial Hospital.

License Records

John Buse

License #:

37804 - Active

Category:

Professional

Issued Date:

Jul 1, 2002

Expiration Date:

Sep 30, 2017

Resumes

John Buse

View page

Business Records

Name / Title

Company / Classification

Phones & Addresses

John Buse
Chief Executive Officer, CEO

Buse Industries, LLC
Manufacturing Electronic Components · Mfg Electronic Components Engineering Services · Mfg Elec Components Engineering Services Whol Electrical Equip Mfg Elec Connectors · Electrician · Other Electronic Component Mfg · Electronic Components, NEC · Electronic Connectors

177 NW Industrial Ct, Hazelwood, MO 63044
(314) 344-1166, (314) 395-2404, (314) 344-1131, (314) 344-9194

News

Even as obesity rates climb, new diabetes cases fall

View page

We might have mined out a lot of the previously unrecognized cases and so new diagnoses in the last several years are more likely to be actual new illnesses, said Dr. John Buse, a University of North Carolina diabetes expert.

Date

May 28, 2019

Category:

Health

Source:

Google

New "Smart Cell Patch" Developed to Control Diabetes

View page

Managing diabetes is tough for patients because they have to think about it 24 hours a day, seven days a week, for the rest of their lives, said co-author John Buse, M.D., Ph.D., professor of medicine at the UNC School of Medicine and director of the UNC Diabetes Care Center and the NC Translation

Date

Mar 15, 2016

Category:

Health

Source:

Google

'Smart Insulin' Could Control Blood Sugar Without A Painful Needle Prick

View page

"Injecting the wrong amount of medication can lead to significant complications like blindness and limb amputations, or even more disastrous consequences such as diabetic comas and death," said John Buse, co-senior author of thePNASpaper and the director of the UNC Diabetes Care Center.

Date

Jun 23, 2015

Category:

Health

Source:

Google

Screen for Pre-Diabetes, Experts Say

View page

In an editorial inDiabetes Care, the four researchers -- Lawrence Phillips, MD, of Emory University, Robert Ratner, MD, of the American Diabetes Association, John Buse, MD, PhD, of the University of North Carolina at Chapel Hill, and Steven Kahn, MD, of the University of Washington -- said there

Date

Sep 29, 2014

Category:

Health

Source:

Google

Diabetes complications drop dramatically, says CDC

View page

"The prognosis for folks with diabetes has improved dramatically over the last two decades, at least for those with good access to care," said Dr. John Buse, a University of North Carolina diabetes specialist, said in an email. He was not involved in the study.

Date

Apr 17, 2014

Category:

Health

Source:

Google

Google to Launch “Smart' Contact Lenses for Diabetics?

View page

Dr. John Buse from University of North Carolina, a diabetes researcher says that "the outsourced clinical study with some real patients was encouraging, but there are many potential pitfalls yet to come. This has the potential to be a real game changer, but the devil is in the details."

Date

Jan 17, 2014

Category:

Health

Source:

Google

Google develops contact lens glucose monitor

View page

An early, outsourced clinical research study with real patients was encouraging, but there are many potential pitfalls yet to come, said University of North Carolina diabetes researcher Dr. John Buse, who was briefed by Google on the lens last week.

Date

Jan 16, 2014

Category:

Health

Source:

Google

ADA: No Cancer Risk with Lantus

View page

A U.S. study similarly found no increased risk of any of those cancers among new glargine users compared with NPH insulin when they were followed for about a year, John Buse, MD, PhD, of the University of North Carolina at Chapel Hill, and colleagues reported.

Date

Jun 12, 2012

Category:

Health

Source:

Google

Publications